Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT01239004
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 140 participants
- Sponsor
- Radiant Research
- Registry
-
NCT01239004
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01239004. Randomized; quadruple masking; primary purpose prevention. Start 2010-11 (registry gives no type); primary completion 2011-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
- Acronym
- CERTAIN
- Condition
- Dyslipidemia
- Condition
- Hyperlipidemia
- Condition
- Hyperglycemia
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Colesevelam
- Lead sponsor
- Radiant Research
Record details
- Record id
cardio:ct-nct01239004- Content hash
4ca54d639b643673268980a96af1fe2ee4f5889fb94d093ddd34f97fda6a1363